2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions

View by Date

Saturday, April 29, 2017

5:30pm-7:30pm: Validation of CYP4F11 as a Marker of Accommodation in Biopsies from Recipients of an ABO-Incompatible Renal Transplant.

K. Dominy,¹ M. Willicombe,³ T. Al Johani,² J. Galliford,³ A. McLean,³ T. Cook,³ C. Roufosse.³

Poster Session A: Diagnostics/Biomarkers Session I • Hall D1

5:30pm-7:30pm: Validation of a Novel Computational Approach for Predicting HLA Immunogenicity Based on Quantification of Structural and Surface Electrostatic Potential Differences Between Donor and Recipient HLA.

V. Kosmoliaptsis,¹ C. Kling,² M. Robb,³ D. Collett,³ J. Bradley,¹ C. Taylor,¹ D. Kabelitz,² D. Mallon.¹

Poster Session A: Diagnostics/Biomarkers Session I • Hall D1

5:30pm-7:30pm: Variations in Risk-Appetite Between UK Kidney Transplant Centres and Impact on Patient and Graft Outcomes.

P. Trotter,^1,2 M. Robb,² D. Summers,^1,2 J. Bradley,¹ J. Neuberger,^2,4 C. Callaghan.^2,3

Poster Session A: Deceased Donor Issues I: Allocation, KDPI and Recipient Selection • Hall D1

5:30pm-7:30pm: Vendor to Center in 0-60: A Cost-Effective Blueprint for Creating an In-House On-Call System for Abdominal Organ Offers.

J. Davenport, D. Cassidy, A. Hauser, A. Milling, K. Driggers, H. Crego, J. Anderson, L. Curry, P. Baliga, N. Pilch, D. Dubay.

Poster Session A: Transplant Economics and Pharmacy Value Initiatives • Hall D1

5:30pm-7:30pm: Which Is More Nephrotoxic to Kidney Transplants: BK Nephropathy or Rejection?

S. Parajuli, B. Astor, D. Kaufman, B. Muth, M. Mohamed, N. Garg, A. Djamali, D. Mandelbrot.

Poster Session A: Kidney: Polyoma • Hall D1

5:30pm-7:30pm: Which Way to Go, Liver Resection or Liver Transplantation for Hepatocellular Carcinoma in Child A Liver Cirrhosis.

K. Yoon, K.-W. Lee, H. Kim, D. Oh, H.-S. Kim, S. Ahn, S. Hong, N.-J. Yi, K.-S. Suh.

Poster Session A: Clinical Science: Liver - Hepatocellular Carcinoma and Cholangiocarcinoma Malignancies • Hall D1

5:30pm-7:30pm: Willingness of End-Stage Renal Disease Patients (ESRD) without Hepatitis C (HCV) to Accept a HCV+ Kidney.

P. Reese,¹ D. Goldberg,¹ A. Mussell,¹ M. McCauley,¹ D. Sawinski,¹ N. Molina,² R. Tomlin,² S. Doshi,¹ P. Abt,¹ E. Blumberg,¹ C. Thiessen,² S. Kulkarni,² G. Esnaola.²

Poster Session A: Viral Conundrums • Hall D1

5:30pm-7:30pm: Willingness to Donate Organs Among Persons Living with HIV.

S. Halpern, K. Kumar, A. Nguyen, S. Rasmussen, S. Anjum, A. Massie, A. Tobian, D. Segev, J. Sugarman, C. Durand.

Poster Session A: Viral Conundrums • Hall D1

5:30pm-7:30pm: Women in the United States Receive More Resections and Ablations for Hepatocellular Carcinoma Than Men.

L. Sobotka,¹ A. Hinton,² L. Conteh.¹

Poster Session A: Clinical Science: Liver - Hepatocellular Carcinoma and Cholangiocarcinoma Malignancies • Hall D1

5:30pm-7:30pm: Zero-Time Biopsy of Potential Donor Kidneys to Aid Decision-Making: A 9-Year Single-Center Experience.

Y. Luque, O. Aubert, F. Martinez, L. Amrouche, C. Tinel, L. Galmiche, L.-H. Noel, J.-P. Duong, F. Audenet, C. Legendre, D. Anglicheau, M. Rabant.

Poster Session A: Deceased Donor Issues I: Allocation, KDPI and Recipient Selection • Hall D1